We demonstrate that patients with luminal B tumors derive clinically meaningful benefits … from the addition of apalutamide to secondary radiotherapy,” Dr Daniel Spratt said, adding that these ...

Standardized evaluation protocol improved transfer, ECSL outcomes, and re-transfer to discharge for pediatric hematologic oncology patients.

HealthDay News — More severe exposures to World Trade Center (WTC) dust increase the risk for developing lung cancer, according to a study published online Oct. 9 in JAMA Network Open.

Researchers compared HRQoL outcomes, measured by patient-reported outcomes, among frail patients with newly diagnosed MM who received Isa-VRd vs VRd alone.

Current smoking was the most important predictor for a detrimental effect of aspirin on cancer incidence, whereas CHIP was the most important predictor for a beneficial effect of aspirin,” researchers ...

Ensartinib “provides a new choice for treating stage IB/II/III, ALK-positive NSCLC following complete resection,” said Dongsheng Yue, MD.

An oncology social worker describes 3 nature-focused strategies — forest bathing, horticultural therapy, and animal-assisted therapy — that can help patients with cancer.

Taken together with previous observational, genomic, and early trial data, our findings support the integration of aspirin into clinical practice for a molecularly defined subgroup of patients with ...

Since its approval, there have been no cases of torsades de pointes or unexplained sudden death among US patients treated with Caprelsa.

This is likely the first case report on primary cutaneous follicle center lymphoma associated with bone marrow mastocytosis.

The DESTINY-Breast05 trial included patients with HER2-positive primary breast cancer who were at high risk of recurrence and had residual invasive disease in breast or axillary lymph nodes following ...

Emerging therapies such as bezuclastinib and elenestinib show promise in improving disease control with potentially fewer toxicities. Other novel strategies, such as immune-based therapies, are under ...